Get the latest Science News and Discoveries

Lyme vaccine hits 70%+ protection in phase 3


Pfizer is testing a new Lyme disease vaccine in over 12,500 people aged 5+. This Phase 3 trial aims to prevent infection in high-risk areas. NCT ID: NCT05477524.

None

Get the Android app

Or read this on r/EverythingScience

Read more on:

Photo of phase

phase

Photo of protection

protection

Photo of Lyme vaccine

Lyme vaccine

Related news:

News photo

Meningitis Outbreak Exposes UK's Decade-Long Gap in Protection

News photo

Romiplostim prevents serious side effect of chemotherapy in phase 3 trial - EurekAlert!

News photo

p62 links protein aggregates to protection in alcohol-associated liver disease - EurekAlert!